Simvastatin antagonizes tumor necrosis factor-α inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway

Misuzu Yamashita(Okayama University), Hirofumi Makino(Okayama University)

Journal of Endocrinology

January 3, 2008

10.1677/joe-07-0532

Cited by 118

Related Papers

Innate immunity in diabetes and diabetic nephropathy

|Nature Reviews Nephrology|2015|424

The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis

|Arthritis Research & Therapy|2006|321

Visceral Adipose Tissue-derived Serine Proteinase Inhibitor Inhibits Apoptosis of Endothelial Cells as a Ligand for the Cell-Surface GRP78/Voltage-dependent Anion Channel Complex

|Circulation Research|2013|85

Differential Regulation of Steroidogenesis by Bone Morphogenetic Proteins in Granulosa Cells: Involvement of Extracellularly Regulated Kinase Signaling and Oocyte Actions in Follicle-Stimulating Hormone-Induced Estrogen Production

|Endocrinology|2006|81

Mutual Regulation of Follicle-Stimulating Hormone Signaling and Bone Morphogenetic Protein System in Human Granulosa Cells1

|Biology of Reproduction|2006|74